Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03767062Completed
Randomised, open-label trial of topiramate in medication overuse headache (MOH) and chronic migraine (2 arms), sponsored by Atatürk University. Primary endpoints: Visual Analog Scale at 4 weeks and Headache Attack Frequencies at 4 weeks. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03767062.